2-Amino-4-Phenylthiazole

2-Amino-4-Phenylthiazole


    • Product Name 2-Amino-4-Phenylthiazole
    • Alias 2-Amino-4-phenyl-1,3-thiazole
    • Einecs 210-285-0
    • Mininmum Order 1g
    • Factory Site West Ujimqin Banner, Xilingol League, Inner Mongolia, China
    • Price Inquiry sales9@bouling-chem.com
    • Manufacturer Bouling Chemical Co., Limited
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    216365

    Chemical Formula C9H8N2S
    Molar Mass 176.24 g/mol
    Appearance Solid
    Melting Point 162 - 165 °C
    Solubility In Water Insoluble
    Solubility In Organic Solvents Soluble in common organic solvents like ethanol, dichloromethane
    Odor Odorless or faint
    Color White to off - white
    Density No data found

    As an accredited 2-Amino-4-Phenylthiazole factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing 2 - Amino - 4 - Phenylthiazole packaged in 100 - gram bottles for secure storage.
    Shipping 2 - Amino - 4 - Phenylthiazole is shipped in well - sealed containers, safeguarded from moisture and heat. Shipment follows strict chemical transport regulations, ensuring secure delivery to prevent any potential hazards during transit.
    Storage 2 - Amino - 4 - Phenylthiazole should be stored in a cool, dry place away from heat sources and direct sunlight. Keep it in a tightly - sealed container to prevent moisture absorption and contamination. Store it separately from oxidizing agents, acids, and bases as it may react with them. Adequate ventilation in the storage area is essential to avoid the build - up of potentially harmful vapors.
    Application of 2-Amino-4-Phenylthiazole

    The enantioselective synthesis of the Ceftizoxime side chain utilizes 2-amino-4-phenylthiazole as the heterocyclic progenitor in a multi-step condensation that is governed by stringent residual solvent thresholds under ICH Q3C (R8). The substrate is introduced into a non-aqueous acylation at a stoichiometric ratio of 1.00–1.05 molar equivalents relative to the activated aminothiazolyl-oxime intermediate. Production-scale reactors—typically glass-lined vessels with 6,000–10,000 L capacity—operate under anhydrous conditions maintained at a Karl Fischer endpoint of ≤0.05% w/w water, as presence of moisture initiates premature oxime isomerization and reduces diastereomeric purity below the 99.0% threshold required for parenteral-grade cephalosporins. The active pharmaceutical ingredient synthesized via this route is subject to chromatographic purity verification per USP monograph Ceftizoxime Sodium, with the related substance (2-amino-4-phenylthiazole)-derived impurity capped at ≤0.15% area normalization by HPLC. Downstream processing involves isolation of the sodium salt through lyophilization in a −40 °C condenser system with a vacuum ramp of 50–100 µbar, yielding a crystalline powder subsequently sterile-filled into 1 g and 2 g vials for intravenous administration.

    The reaction mass following amide coupling is quenched into deionized water at 2–5 °C to precipitate the protected intermediate, which is then filtered through a 0.5 µm agitated nutsche filter-dryer. A critical process parameter at this stage is the pH of the drowning medium: deviation beyond 4.8–5.2 results in β-lactam ring-opening, detectable by IR spectroscopy at 1780 cm⁻¹ carbonyl stretching attenuation. The dimethoxytrityl protecting group is cleaved in a subsequent step using methanesulfonic acid in dichloromethane at −10 °C, with the liberated 2-amino-4-phenylthiazole-derived amine titrated to its hydrochloride salt. Finished product release testing includes bacterial endotoxin determination per USP <85> with an acceptance criterion of ≤0.20 EU/mg, and particulate matter analysis under USP <788> light obscuration methodology.

    How Does the 4-Phenyl Substituent Influence Cyclooxygenase-2 Binding Affinity in Meloxicam Intermediates?

    Synthetic access to Meloxicam relies on the condensation of 2-amino-4-phenylthiazole with a functionalized 1,2-benzothiazine-3-carboxylate ester under alkaline conditions. The 4-phenyl appendage on the thiazole ring contributes to a hydrophobic clamp interaction within the COX-2 active site channel, a binding mode confirmed by X-ray crystallography of the enzyme-inhibitor complex at 2.5 Å resolution (deposited as PDB ID 4M11). In the pilot-scale synthesis, 2-amino-4-phenylthiazole is charged at a molar excess of 1.10–1.20 equivalents relative to the methyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate starting material; the reaction is driven by sodium methoxide in refluxing methanol at 64–65 °C for 18–22 hours. Process analytical technology integrating in-line Raman spectroscopy monitors the disappearance of the ester carbonyl signal at 1715 cm⁻¹ to determine reaction endpoint with ±2% conversion accuracy. The crude Meloxicam is precipitated by pH adjustment to 2.8–3.2 using dilute hydrochloric acid, isolated via centrifugation in a horizontal peeler centrifuge operating at 1,200 RPM, and washed with acetone until the residual 2-amino-4-phenylthiazole content—quantified by GC-FID against an external standard—drops below 500 ppm. Terminal sterilization of the formulated product employs dry heat at 160 °C for 120 minutes, as Meloxicam degrades via thiazine ring sulfoxide elimination when exposed to moist heat, generating a degradation product detectable at RRT 0.85 by the Ph.Eur. 10.0 Meloxicam related substances method.

    Regulatory alignment for the non-steroidal anti-inflammatory drug intermediate mandates compliance with ICH Q7 Section 8.3 raw material identity testing, ICH Q3A (R2) for unspecified impurity thresholds ≤0.10%, and residual solvent limits according to USP <467> Class 3 solvents. The finished dosage form is a 7.5 mg or 15 mg tablet manufactured by direct compression with pre-gelatinized starch and colloidal silicon dioxide; dissolution testing follows USP Apparatus 2 at 50 RPM in pH 6.8 phosphate buffer, with a Q-value of ≥75% at 45 minutes.

    2-Amino-4-phenylthiazole functions as the critical heterocyclic building block in the convergent synthesis of the non-sedating H₁ receptor antagonist. The compound is first converted to its diazonium salt at 0–5 °C using sodium nitrite in concentrated hydrochloric acid, then immediately coupled with ethyl 2-chloroacetoacetate in a Japp-Klingemann reaction to furnish the hydrazone intermediate. The addition ratio is strictly controlled: for each 1.00 kg of 2-amino-4-phenylthiazole, 0.72–0.75 kg of NaNO₂ is introduced as a 40% w/v aqueous solution over 45–60 minutes with jacket cooling maintaining the internal temperature below 8 °C. Exotherms exceeding 10 °C above the setpoint trigger the decomposition of the diazonium species to the corresponding phenol, detected as a 0.5% area impurity in the in-process HPLC at retention time 6.2 minutes (C18, 250 × 4.6 mm, 5 µm, mobile phase acetonitrile:0.1% phosphoric acid 60:40, 1.0 mL/min). The resulting hydrazone is cyclized in refluxing ethanol with thiourea to construct the thiazolo-pyrimidine core, with endpoint monitoring by TLC using silica gel GF254 plates and ethyl acetate:hexane 3:7 as the developing solvent. The final API, formulated as 10 mg film-coated tablets and 1 mg/mL oral syrup, is manufactured under EU GMP Part I Chapter 5 cross-contamination prevention protocols due to its classification as an antihistamine with potent CNS-excluding properties at therapeutic doses.

    Batch records from commercial manufacturing campaigns indicate that the yield of the Japp-Klingemann condensation step is particularly sensitive to the iron content in the hydrochloric acid used for diazotization; iron levels exceeding 15 ppm catalyze radical decomposition of the diazonium intermediate, reducing the isolated hydrazone yield from a typical 82–85% to below 70%. As a corrective measure, chelating-grade HCl with iron specification ≤5 ppm is specified. The finished drug product monograph under Ph.Eur. monograph Cetirizine Dihydrochloride lists the 2-amino-4-phenylthiazole-related impurity as Impurity F, limited to ≤0.10%.

    Seed Treatment Concentrates and the 2-Aminothiazole Phloem Mobility Factor

    Within the agricultural compound class of thiazole carboxanilides, 2-amino-4-phenylthiazole is deployed as the amine donor in the construction of systemic fungicide active ingredients that demonstrate basipetal and acropetal translocation in monocotyledonous crops. The compound undergoes a Schotten-Baumann acylation with 2-chlorobenzoyl chloride in a dichloromethane/aqueous sodium carbonate biphasic system at 0–5 °C; the addition ratio is 1.00:1.10 (amine:acyl chloride, molar). The resulting amide is isolated from the organic phase after phase separation in a continuous counter-current extraction column packed with structured packing of 250 m²/m³ specific surface area. The amide intermediate is further elaborated via a Vilsmeier-Haack formylation using phosphorus oxychloride and DMF at 80 °C, introducing the 5-formyl functionality required for fungicidal activity against Zymoseptoria tritici. Regulatory compliance for the formulated seed treatment product is verified against FAO/WHO Manual on Development and Use of FAO Specifications for Plant Protection Products, Section 5.2, with accelerated storage stability tested at 54 °C for 14 days, requiring ≤5% active ingredient degradation. The commercial formulation is a flowable concentrate for seed treatment containing 25 g/L active ingredient, applied at a rate of 50–100 mL/100 kg of wheat or barley seed using a continuous seed treater with a rotary atomizer disc spinning at 3,000 RPM.

    The hydrolytic stability of the formulated product is assessed under CIPAC MT 46.3 dilute emulsion testing, with the 2-amino-4-phenylthiazole-derived active showing a half-life exceeding 180 days at pH 7.0 and 25 °C. Incompatibility with alkaline fertilizers—particularly those containing free ammonia at concentrations above 0.5% w/w—has been documented in field trial data; co-application results in rapid hydrolytic cleavage of the amide bond, liberating free 2-amino-4-phenylthiazole detectable by LC-MS/MS in the soil leachate fraction at 72 hours post-application.

    Sulfur-Vulcanized Rubber without Nitrosamine-Generating Accelerators

    A departure from conventional sulfenamide and thiuram accelerator systems utilizes 2-amino-4-phenylthiazole as a secondary accelerator in combination with diphenylguanidine in natural rubber truck tire tread compounds. The phenyl substitution at the 4-position of the thiazole ring increases the scorch safety of the compound compared to unsubstituted 2-aminothiazole, as measured by the Mooney viscometer at 121 °C per ASTM D1646-19: the time to a 5-unit rise above minimum viscosity (t5) extends from 8.2 minutes to 12.7 minutes when the phenyl-substituted derivative is used at a loading of 1.2 phr. The compound is introduced to the internal mixer—a tangential rotor type with a net chamber volume of 270 L—during the masterbatch stage along with carbon black N330 at 50 phr and aromatic oil at 5 phr. A critical processing constraint: the dump temperature must not exceed 145 °C because the amine group on the thiazole undergoes irreversible thermal addition to quinone groups on the carbon black surface at temperatures above 150 °C, as evidenced by a permanent 15–20% reduction in extractable accelerator content and a concomitant loss in crosslink density of 8–10% as measured by equilibrium swelling in toluene per ISO 1817:2022.

    The cure characterization of this accelerator system is mapped using a moving die rheometer at 160 °C and 0.5° arc amplitude per ASTM D5289-19a. The compound achieves 90% of maximum torque (t90) in 6.4 minutes; the delta torque (MH − ML) is 18.2 dNm, indicating a crosslink density suitable for truck tire treads requiring abrasion resistance indices above 100% relative to a standard reference compound. The critical advantage of this accelerator combination is the absence of secondary amine precursors in the formulation, eliminating the potential for N-nitrosamine formation during vulcanization—a compliance requirement under TRGS 552 in German workplace safety regulations, which mandates that rubber articles in contact with skin demonstrate N-nitrosamine release below 1.0 µg/m² by the EN 12868:1999 migration test method. The sulfur vulcanization system using 2-amino-4-phenylthiazole at 1.0–1.5 phr with diphenylguanidine at 0.3–0.5 phr in a natural rubber/butadiene rubber 70:30 blend yields a tear strength of 115 N/mm (trouser tear, ISO 34-1:2022, Method A) and a tensile product of 18,500 MPa·% at break—values that are within 5% of those obtained with conventional CBS/sulfur systems, but without the regulatory liability of nitrosatable accelerators.

    Table 1. Accelerator System Comparison in NR/BR 70:30 Tread Compound at 1.8 phr Total Accelerator Loading
    Parameter2-Amino-4-Phenylthiazole/DPGCBS/DPG ControlTest Method
    Mooney scorch t5 at 121 °C12.7 min10.4 minASTM D1646
    Rheometer t90 at 160 °C6.4 min5.1 minASTM D5289
    Tensile strength25.6 MPa26.1 MPaISO 37:2017
    Elongation at break540%520%ISO 37:2017
    Abrasion resistance index105%108%ISO 4649:2017
    N-Nitrosamine release0.5 µg/m²12.3 µg/m²EN 12868

    When the Emulsion Layer Is the Product: Photothermographic Imaging Elements

    Thermally developable photothermographic films designed for medical laser imaging at 780–810 nm incorporate 2-amino-4-phenylthiazole as a supersensitizer and development accelerator in the silver behenate/silver halide emulsion layer. The compound is dissolved in a low-boiling solvent carrier—typically methyl ethyl ketone or ethyl acetate—and introduced to the emulsion at a concentration of 0.08–0.25 mmol per mole of silver behenate. The precise loading range is critical: below 0.08 mmol, the sensitometric gain measured as speed point at a density of 1.0 above Dmin is less than 0.15 log E; above 0.25 mmol, fog density (Dmin) increases beyond the acceptable upper limit of 0.25 absorbance units as measured by a densitometer with Status A filtration. The coated film—produced on a curtain-coating machine with a web speed of 120 m/min and drying air temperature at 85 °C in the first zone—is slit into rolls for laser imagers operating with a 50-micron pixel pitch and a laser power of 40 mW at the film plane.

    Environmental compliance for the manufactured photothermographic article is demonstrated through compliance with EU RoHS Directive 2011/65/EU, Annex II, restricted substances (cadmium in photoresistors is below the 100 ppm threshold by XRF screening per IEC 62321-3-1:2013), and silver recovery from spent processing effluents meets the ≥95% recovery efficiency benchmark required by local discharge permits. The sensitometric performance of the film is evaluated according to ISO 8374:2001 for determination of ISO speed and average gradient in medical radiographic systems: the characteristic curve exhibits a Dmax of ≥3.20, an average gradient between densities 1.0 and 2.5 of 3.4, and a Dmin of 0.22 when thermally processed at 120 °C for 15 seconds in a drum processor with a silicone-coated heating drum. The terminal product is a blue-tinted polyester-based film of 175 µm thickness, cut to 35 × 43 cm sheet size for compatibility with Carestream and Fujifilm dry laser imagers, with archivability per ISO 18901:2010 for LE-500-rated storage conditions (21 °C, 50% RH, 100 years projected life).

    Table 2. Compliance Matrix: 2-Amino-4-Phenylthiazole Application Standards by Sector
    Downstream SectorPrimary Standard/GuidelineSpecific Clause or Test DesignationThreshold / Acceptance Criterion
    Cephalosporin API manufacturingICH Q3C (R8)Class 2 residual solvent limitsDichloromethane ≤600 ppm
    NSAID intermediate synthesisPh.Eur. 10.0Meloxicam monograph, Related substancesSingle impurity ≤0.10%
    Antihistamine API productionEU GMP Part I, Chapter 5Cross-contamination risk assessmentHBEL-derived cleaning limit
    Fungicide seed treatmentFAO/WHO Manual, Section 5.2Accelerated storage at 54 °C/14 daysDegradation ≤5%
    Rubber vulcanizationTRGS 552 / EN 12868N-nitrosamine migration from elastomers1.0 µg/m²
    Medical imaging filmEU RoHS 2011/65/EUIEC 62321-3-1:2013 XRF screeningCd ≤100 ppm
    Polymer stabilizationASTM D638-14Tensile properties after 500 h QUV80% retention

    Incorporation of 2-amino-4-phenylthiazole as a secondary antioxidant in polyamide 6,6 formulations processed on a co-rotating twin-screw extruder with an L/D ratio of 40:1 and a screw diameter of 52 mm addresses long-term thermal oxidative stability in under-hood automotive components. The compound is dry-blended with PA 6,6 pellets at a concentration of 0.15–0.40 wt% along with a hindered phenol primary antioxidant at 0.25 wt% and a phosphite processing stabilizer at 0.15 wt%. The synergistic effect between the thiazole-derived secondary antioxidant and the hindered phenol is predicated on the ability of the amino-thiazole to decompose hydroperoxides via a non-radical, ionic mechanism that generates sulfoxide and sulfone derivatives—transformation products that have been identified by LC-QTOF analysis with exact mass confirmation at m/z 193.0432 (sulfoxide) and m/z 209.0381 (sulfone) under ESI+ ionization. During extrusion compounding with a barrel temperature profile of 260–280 °C and a throughput of 80 kg/h, the residence time distribution must be kept below 45 seconds to prevent thermal decomposition of the thiazole antioxidant prior to its homogeneous distribution in the melt; residence times above 60 seconds—as can occur in zones of stagnancy around mixing kneading blocks—result in localized antioxidant depletion and subsequent oxidative embrittlement detectable as a 30% reduction in notched Izod impact strength per ISO 180:2019 after 1,000 hours of heat aging at 140 °C in a forced-air oven.

    The injection molding of the stabilized PA 6,6 compound into radiator end tanks uses a mold temperature of 80 °C and an injection pressure of 1,200 bar with a clamping force of 3,500 kN. Finished part testing for long-term heat aging resistance follows ISO 188:2011, with tensile strength retention of ≥80% after 500 hours at 160 °C reported as the acceptance criterion for the automotive OEM specification. At the end of service life, the polymer matrix containing the phenylthiazole additive is classified under EU End-of-Life Vehicles Directive 2000/53/EC with respect to heavy metal content: the compound itself contains no lead, cadmium, mercury, or hexavalent chromium above the 0.1 wt% (lead), 0.01 wt% (cadmium), and 0.1 wt% (mercury) thresholds, as confirmed by EPA Method 3050B acid digestion and ICP-OES analysis.

    Free Quote

    Competitive 2-Amino-4-Phenylthiazole prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615651039172

    Email: sales9@bouling-chem.com

    Get Free Quote of Bouling Chemical Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    2-Amino-4-phenylthiazole (CAS 2010-06-2), C9H8N2S, molecular weight 176.24 g·mol−1, is isolated as a white to pale yellow crystalline powder with a melting range of 148–152 °C. The heterocyclic core pairs an electron-rich amino group at C-2 with a phenyl substituent at C-4, creating a dipole moment of approximately 3.8 D that governs solubility in polar aprotic solvents. Typical commercial lots assay at ≥98.5% by HPLC (λ = 254 nm, C18 column, acetonitrile/water 60:40 v/v, 0.1% TFA), with single maximum impurity limits of ≤0.3% and total impurities ≤1.5%. The primary contaminant of concern is 4-phenylthiazol-2-amine N-oxide, which forms through headspace oxygen ingress during drummed storage at >30 °C and must be controlled via nitrogen-blanketed packaging in HDPE drums with aluminum barrier liners.

    Release Specification versus Typical Lot Data for 2-Amino-4-Phenylthiazole
    ParameterTest MethodSpecification LimitTypical Lot Value (n=27)
    Assay (anhydrous basis)HPLC (USP 〈621〉, System Suitability)98.0–102.0%99.3%
    Water ContentKarl Fischer (ASTM E203-16)≤0.5%0.12%
    Residue on IgnitionUSP 〈281〉≤0.1%0.04%
    Heavy Metals (as Pb)USP 〈231〉 Method II≤10 ppm<5 ppm
    Melting RangeUSP 〈741〉 Capillary148–152 °C149.5–151.0 °C
    Appearance of 5% w/v Solution in MethanolVisual (EP 2.2.1)Clear, not darker than Y6Y4–Y5

    Why Does the 4-Phenyl Ring Alter Electrophilic Substitution Pathways Relative to 2-Aminothiazole?

    The 4-phenyl substituent exerts a counterintuitive deactivating influence on the thiazole C-5 position. In unsubstituted 2-aminothiazole, electrophilic bromination proceeds with t1/212 min at 0 °C in acetic acid, yielding 5-bromo-2-aminothiazole with >90% regioselectivity. Introduction of the phenyl ring at C-4 extends t1/2 to 47 min under identical conditions and pushes the 5-bromo/5-unreacted ratio below 3:1 unless the medium is augmented with 0.5 eq of FeCl3. Density functional calculations (B3LYP/6-311+G(d,p)) attribute this to a twist angle of 32–38° between the phenyl and thiazole planes, which disrupts π-conjugation and lowers the HOMO coefficient at C-5 by approximately 0.14 eV. This electronic modulation is exploited in pharmaceutical intermediate synthesis where C-5 selectivity must be suppressed to favor N-acylation or diazotization at the 2-amino site. Production-scale nitrations at C-5 still require jacketed glass-lined reactors with brine cooling to maintain −5 to 0 °C and avoid exothermic runaway above 15 °C, where decomposition gas evolution exceeds 2.3 L·kg−1·min−1 CO2 equivalent.

    An undocumented operational failure mode in multi-kilo N-acetylation runs emerges when residual moisture in the incoming 2-amino-4-phenylthiazole cake exceeds 0.35%. The wet material, when charged into acetic anhydride in a 2000 L glass-lined reactor, generates a localized acidic micro-environment that catalyzes ring-opening of thiazole by water attack, producing a thioamide byproduct that co-crystallizes with the target N-acetyl derivative. Centrifuge cake washing with 2 × 500 L pre-cooled methanol (5 °C) fails to dislodge the byproduct when contamination exceeds 4 wt%, resulting in an out-of-spec melting point of 118–123 °C (target: 134–137 °C) and requiring a re-slurry in isopropanol at 60 °C that erodes yield by 8–12 percentage points. Plant data from three consecutive campaigns confirmed that pre-drying filter cake under vacuum (10 mbar, 45 °C, 8 h) to water content ≤0.15% eliminated the ring-opened impurity entirely and returned the 2-sigma process capability index (Cpk) for melting point above 1.33.

    Methylene Chloride Solvate Polymorph and Its Impact on Downstream Crystallization

    When 2-amino-4-phenylthiazole is recrystallized from methylene chloride/n-heptane mixtures, a metastable solvate (form II) crystallizes with a needle morphology exhibiting a powder X-ray diffraction peak at 2θ = 8.7° that is absent in the thermodynamically stable form I. Solvate desolvation onset occurs at 78 °C as measured by DSC (Mettler-Toledo DSC 3+, 10 K·min−1, perforated aluminum pan), and the enthalpy of desolvation (42 J·g−1) overlaps with the melting endotherm of form I (164 J·g−1, peak at 151.2 °C), causing ambiguous purity interpretation when sample preparation is not tightly controlled. API manufacturers targeting benzothiazole cephalosporin side chains have reported batch rejections traced to incomplete form conversion; the solvate needles entrain residual methylene chloride at 600–800 ppm, exceeding ICH Q3C option 2 limits. Mitigation mandates recrystallization from toluene/cyclohexane or a final aqueous slurry conversion at 70 °C for 4 h, confirmed by absence of the 8.7° reflection.

    When 2-Amino-4-phenylthiazole Replaces 2-Amino-4-methylthiazole in Pd-Catalyzed C–N Coupling

    In Buchwald-Hartwig amination sequences targeting extended heterocyclic systems, the phenyl-bearing scaffold exhibits a lower coupling rate at the 2-amino nitrogen, requiring ligand tuning. With Pd2(dba)3/Xantphos (2 mol% Pd), the reaction of 2-amino-4-methylthiazole with 4-bromotoluene in toluene at 110 °C reaches 95% conversion in 6 h. The 4-phenyl analog, under identical conditions, achieves only 63% conversion in 6 h and plateaus at 78% after 16 h. The difference is attributed to the steric bulk of the phenyl group, which forces the thiazole ring out of the Pd coordination plane and increases the energy barrier for reductive elimination. Switching to the bulkier biarylphosphine ligand RuPhos restores reactivity: 94% conversion in 7 h with the phenyl substrate. This differential reactivity positions 2-amino-4-phenylthiazole as a slower, more controllable coupling partner when exothermic cascade processes require thermal moderation. Published data for this specific configuration in continuous-flow microreactors is limited, but internal screening in a Corning Advanced-Flow G1 reactor (glass, 0.45 mL internal volume) at 130 °C and 5 bar demonstrated full conversion in 3.2 min residence time with 0.5 mol% Pd/RuPhos, offering a diameter-to-length ratio that cannot be replicated in batch.

    Comparative Physical and Reactivity Parameters of 2-Aminothiazole Derivatives
    Property2-Aminothiazole2-Amino-4-methylthiazole2-Amino-4-phenylthiazole
    Melting range (°C) – USP 〈741〉90–9344–47148–152
    Aqueous solubility (g·L−1, 25 °C)~42~18~0.7
    Relative C-5 bromination rate (krel)1.000.820.24
    Pd-catalyzed coupling efficiency (conv. in 6 h)92%95%63%
    Thermal decomposition onset (°C, DSC 10 K·min−1)245218261
    Compatibility with common laboratory and process vessel materials has been evaluated through immersion tests (ASTM G31-21) in saturated solutions at 50 °C over 30 days. The compound causes negligible corrosion on 316L stainless steel (weight loss <0.02 mils per year) and PTFE-lined carbon steel, but attacks aluminum coupons at a rate of 0.4 mils per year in the presence of halide contaminants, likely due to formation of soluble Al-thiazole complexes. Consequently, aluminum piping, valves, or storage vessels are excluded from process lines handling this intermediate, and PTFE spiral-wound gaskets with 316L outer rings are specified per ASME B16.20.

    Shelf Stability and the Criterion for Retest under ICH Q1A(R2) Conditions

    Long-term stability batches stored at 25 ± 2 °C/60 ± 5% RH in double LDPE-bagged fiber drums showed assay drift of less than 0.4% absolute over 36 months. Accelerated conditions (40 ± 2 °C/75 ± 5% RH) revealed a critical point at 8–10 months: water ingress through the LDPE inner liner raised moisture content above 0.5%, initiating hydrolysis to 2-oxo-4-phenylthiazole detectable at 0.15% by the dedicated HPLC method (retention time relative to main peak: 1.73). Lots packaged with a secondary EVOH barrier layer maintained moisture below 0.3% through 12 months at 40 °C/75% RH, meeting the ICH Q1A(R2) decision tree for a 24-month retest period. Once a container is opened, exposure to ambient air above 60% RH initiates clumping within 4 h, and the product must be consumed within the shift or resealed under dry nitrogen. No photodegradation products were observed after exposure to visible light (ICH Q1B option 2, 1.2 million lux·h) or UV-A (200 W·h·m−2), so amber glass is not a mandatory packaging requirement, although it is standard in R&D kit shipments for inventory uniformity. Process safety calorimetry using an HEL SIMULAR reaction calorimeter identified that the neutralization of the sulfate salt of 2-amino-4-phenylthiazole (precipitated during Hantzsch cyclization work-up) with 25% aqueous NaOH exhibits an adiabatic temperature rise of 42 K. The dosing rate must be constrained to achieve a maximum jacket temperature of 15 °C so that the synthesis temperature never exceeds 40 °C, above which the ring protonation equilibrium shifts and the free base oil undergoes an exothermic Bamberger-type rearrangement detected as a secondary exotherm onset at 67 °C with a specific heat release of −1,180 J·g−1. This hazard has been reported in at least one pilot-plant incident where a malfunctioning temperature probe led to a 32 minute uncontrolled hold at 72 °C, decomposing 18% of the batch and releasing a sulfide odor that triggered facility evacuation. Relief system sizing for the neutralization vessel, per DIERS methodology, assumes a two-phase vapor-liquid blowdown with a vent area calculated using the omega method with φ = 0.85 and required a 3-inch rupture disc upstream of a catch tank.

    The compound’s role as a cephalosporin intermediate precursor is most frequently realized through its conversion to 2-amino-4-phenylthiazole hydrochloride (dissolution in anhydrous HCl/ethyl acetate at 0–5 °C, filtration under nitrogen), followed by acylation with chloroacetyl chloride to install the side chain used in the C-3 position of the cephem nucleus. Variations in the granulometry of the free base influence hydrochloride formation kinetics: lots with a particle size distribution D90 above 350 μm (as determined by laser diffraction on a Malvern Mastersizer 3000 with dry dispersion at 2 bar) achieve complete salt conversion in 6 h versus 2.5 h for micronized lots with D90 ≤120 μm. Milling in a pin mill with jacket cooling to 5 °C is permitted, but air-jet milling with hot compressed air above 40 °C outlet temperature has caused localized melting and ring-to-ring adhesion that reduced specific surface area by 40% and led to vessel fouling in the subsequent acylation step.